Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)

BACKGROUND: Effective treatment options for inoperable, metastatic, or recurrent canine pheochromocytomas are lacking. In humans, specific germline mutations exist that drive the development of pheochromocytomas. Pharmaceutical blockade of these abnormalities with small molecule inhibitors are an ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Musser, Margaret L., Taikowski, Kathryn L., Johannes, Chad M., Bergman, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122699/
https://www.ncbi.nlm.nih.gov/pubmed/30176869
http://dx.doi.org/10.1186/s12917-018-1597-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122699/
https://www.ncbi.nlm.nih.gov/pubmed/30176869
http://dx.doi.org/10.1186/s12917-018-1597-7

Ejemplares similares